Tigris Pharmaceuticals names new chairman
Mr Granadillo served as senior vice president for Eli Lilly and Company until his retirement in 2004 after 34 years of service. Mr Granadillo currently also serves on
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.